Quest Diagnostics Inc
(NYSE:DGX)
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the us. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
top performing DGX trades
Recent Trades
Largest Trades
Top Performing
Largest Traders
Most Active Traders
Recent Trades
View the most recent Quest Diagnostics trades made by congress members.
Earl BlumenauerHouse (D-OR) | $1K - $15K | stock | Sale | May 04, 2024 | Apr 04, 2024 | House |
Tommy TubervilleSenate (R-AL) | $15K - $50K | stock | Sale (Partial) | Feb 15, 2024 | Jan 03, 2024 | Senate |
Thomas R. CarperSenate (D-DE) | $1K - $15K | stock | Sale (Partial) | Jan 03, 2024 | Dec 11, 2023 | Senate |
Carol MillerHouse (R-WV) | $1K - $15K | stock | Purchase | Dec 13, 2022 | Nov 14, 2022 | House |
Kathy ManningHouse (D-NC) | $1K - $15K | stock | Sale | Sep 14, 2022 | Aug 03, 2022 | House |
Kathy ManningHouse (D-NC) | $1K - $15K | stock | Purchase | Aug 10, 2022 | Jul 20, 2022 | House |
Earl BlumenauerHouse (D-OR) | $1K - $15K | stock | Sale | Apr 01, 2022 | Mar 14, 2022 | House |
Earl BlumenauerHouse (D-OR) | $1K - $15K | stock | Purchase | Apr 01, 2022 | Feb 24, 2022 | House |